Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating?

August 28, 2026 · 10:05 pm 2 sources

Image: Yahoo Finance

Coverage

More coverage

• Could Ionis Pharmaceuticals (IONS) Stock Become a Biotech Powerhouse as its Commercial Pipeline Takes Off?
  Yahoo Finance · August 28, 2026 22:05
• Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating?
  Yahoo Finance · August 28, 2026 22:26